• Nanocomposites-based targeted oral drug delivery systems with infliximab in a murine colitis model

    9 days ago - By Journal of Nanobiotechnology

    Infliximab , a TNF-α blocking chimeric monoclonal antibody, induces clinical response and mucosal healing in patients with inflammatory bowel disease. However, systemic administration of this agent ...
    Read more ...